awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q38878906-2AA408D9-5D93-4329-B81D-4FC81D871D7C
Q38878906-2AA408D9-5D93-4329-B81D-4FC81D871D7C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38878906-2AA408D9-5D93-4329-B81D-4FC81D871D7C
Immune checkpoint inhibitor combinations in solid tumors: opportunities and challenges
P2860
Q38878906-2AA408D9-5D93-4329-B81D-4FC81D871D7C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38878906-2AA408D9-5D93-4329-B81D-4FC81D871D7C
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
e6de619a6a3018e05e5aef1e1d4cadf503073746
P2860
Ipilimumab versus placebo after radiotherapy in patients with metastatic castration-resistant prostate cancer that had progressed after docetaxel chemotherapy (CA184-043): a multicentre, randomised, double-blind, phase 3 trial.